Weekly Industry News - Pharma & Healthcare | American Conference Institute

Pharma & Healthcare – this week’s update includes the Healthcare Reform, FTC aiming for $1B pay- for- delay patent settlement and more.

FTC aiming for $1B pay-for-delay patent settlement this year by Arlene Weintraub Published on Fierce Pharma

The Federal Trade Commission is so fed up with “pay-for-delay” pharma deals, that it’s hoping to reach a $1 billion settlement in at least one pharma antitrust case this year. That’s the word from Deborah Feinstein, director of the FTCs Bureau of Competition, who revealed the agency’s aims at a recent meeting of the American Bar Association’s Section of Antitrust Law in Washington, D.C… [ Read More ‘]

Push Comes To Shove: Gilead’s $1,000 Pill Could Hurt Insurer Earnings by Matthew Herper Published on jdsupra

Gilead Sciences’ $1,000-a-day hepatitis C drug, Sovaldi, could hurt the bottom lines of insurance companies, according to an analysis conducted by Leerink, the investment bank… [ Read More ]

Can FSAs Survive Healthcare Reform? by Randall Weill Published on jdsupra

Flexible Spending Accounts (FSAs) or Health FSAs have for years enabled employers to offer employees the opportunity to spend non-taxable compensation on eligible medical expenses. FSAs could not only be used to pay for routine deductibles and co-insurance, but they also could buffer against unexpected health care costs. Now, Health Care Reform under the Affordable Care Act (ACA) has changed the way in which FSAs can be offered to employees… [ Read More ]